Filing Flows

Filing Flows › Bio Essence (BIOE) › Q4 2025

Bio Essence (BIOE) Q4 2025 earnings results (fourth quarter 2025)

10-K filed Mar 27, 2026

Bio Essence (BIOE) reported revenue of $1.5M for the fourth quarter 2025 (Q4 2025), +903% from a year earlier and +981% from the quarter before. Operating margin was 69.6%, net earnings $1.0M (69.6% of revenue).

Revenue$1.5M
Year over year+903%
Quarter over quarter+981%
Operating margin69.6%
Net earnings$1.0M

Bio Essence, Q4 2025: revenue $1.5M (+903% year over year), operating margin 69.6%, net earnings $1.0M, operating cash flow $1.2M. The chart follows the revenue to costs, profit and cash.

Q4 2025AmountQ/QY/Y
Revenue$1.5M+981%+903%
Gross profit$1.1M12×+970%
Operating profit$1.0M72×267×
Net earnings$1.0M79×—
Operating cash flow$1.2M+564%+193%

What changed

Revenue was $1.5M in Q4 2025, up 903% year over year and up 981% from the previous quarter.

Gross margin was 77.3%, up 4.8 points from Q4 2024. Operating profit was $1.0M, a 69.6% margin (up 67.0 points year over year). Of the extra revenue versus Q4 2024, 77% reached operating profit, above the 3% margin then. Operating expenses grew 10% against revenue growth of 903%. Net earnings were $1.0M. The effective tax rate was 0.0%.

Operating cash flow was $1.2M (up 193% year over year), 121% of net earnings. Non-cash charges added back $0K of depreciation and amortization. Working capital and other items added $212K.

Questions

What was Bio Essence's revenue in the fourth quarter 2025?

Bio Essence (BIOE) reported revenue of $1.5M for the fourth quarter 2025 (Q4 2025), +903% from a year earlier and +981% from the quarter before.

Was Bio Essence profitable in the fourth quarter 2025?

Operating profit was $1.0M (69.6% of revenue) and net earnings $1.0M.

Open the interactive Sankey →

Source: Bio Essence 10-K on SEC EDGAR.